Viewing Study NCT05084859


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-02-01 @ 12:46 PM
Study NCT ID: NCT05084859
Status: TERMINATED
Last Update Posted: 2024-08-09
First Post: 2021-09-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Sponsor: Biosplice Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration-resistant Prostate Cancer View
None Non-small Cell Lung Cancer View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SM08502 View
None pan Clk/Dyrk inhibitor View